Joseph Yeater
Physician Assistant · Romney, WVNPI 1487874376
Payments from drug & device makers
Across 179 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$851
- Novo Nordisk$403
- Lilly USA, LLC$315
- Amgen$269
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$241
- Boehringer Ingelheim$159
- plus $985 from 19 others
What the payments were for
- Food & beverage$3,04694%
- Education$1776%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $851 |
| Novo Nordisk | 19 | $403 |
| Lilly USA, LLC | 22 | $315 |
| Amgen | 15 | $269 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $241 |
| Boehringer Ingelheim | 9 | $159 |
| AbbVie | 9 | $150 |
| Amarin Pharma, Inc. | 10 | $143 |
| Johnson & Johnson(2 entities) | 15 | $140 |
| Exact Sciences | 5 | $120 |
| Pfizer | 6 | $110 |
| Novartis | 4 | $76 |
| Sanofi-aventis U.S. LLC | 3 | $43 |
| Abbott | 2 | $36 |
| Dexcom, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Biogen | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Medtronic | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
| Sunovion Pharmaceuticals Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEVESPI AEROSPHERE$122
- AIRSUPRA$122
- FARXIGA$122
- Ozempic$116
How this compares
$3,223 in reported general payments places this provider in the 90th percentile of 833 physician assistant providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 165 | $183,486 |
| JardianceEmpagliflozin | 134 | $133,591 |
| EliquisApixaban | 183 | $132,030 |
| EnbrelEtanercept | 14 | $107,434 |
| Enbrel MiniEtanercept | 12 | $89,693 |
| Humira PenAdalimumab | 12 | $80,010 |
| VraylarCariprazine Hcl | 36 | $59,904 |
| OzempicSemaglutide | 61 | $58,642 |
| TrulicityDulaglutide | 44 | $54,877 |
| XareltoRivaroxaban | 39 | $50,493 |
| JanuviaSitagliptin Phosphate | 44 | $49,967 |
| RybelsusSemaglutide | 23 | $33,599 |
| MounjaroTirzepatide | 23 | $31,597 |
| InvokanaCanagliflozin | 31 | $26,835 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $23,321 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $851 | $205,185192 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $159 | $168,645200 claims |
| PfizerEliquis, Nurtec Odt | $110 | $146,097197 claims |
| AmgenEnbrel | $269 | $107,43414 claims |
| Novo NordiskOzempic, Rybelsus | $403 | $92,24184 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $315 | $86,47467 claims |
| Johnson & JohnsonXarelto, Invokana | $140 | $77,32870 claims |
| AbbVieVraylar, Lumigan | $150 | $63,06448 claims |
| MerckJanuvia | $15 | $49,96744 claims |
| NovartisEntresto | $76 | $12,09520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Romney
- Amy ButtsWellsburg$258K
- Alexander EpperlySouth Charleston$21K
- Kelley WhoolerySouth Charleston$17K
- Jordan BrewerMorgantown$15K
- Tasha ElswickWinfield$14K
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Erik AndersonSouth Charleston$11K
- Catherine EnsingerParkersburg$11K
- Gregory PorterSouth Charleston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.